Skip to main content

Table 1 Clinical indicators of peripheral blood samples

From: Clinical significance and biological roles of lncRNA CTBP1-AS in polycystic ovary syndrome

Clinical indicators

PCOS (N = 85)

Control(N = 40)

t / Z

p value

Age(years)

26(24,29)

28(24, 31)

-1.397

0.163

Duration of infertility (years)

2(1, 4)

2(1, 4)

-0.51

0.61

Menstrual cycles(days)

68(60, 90)

31(30, 40)

-7.907

< 0.001*

Antral follicle count

31(28, 40)

18(15, 20)

-8.358

< 0.001*

Basic sex hormone

    

 FSH (IU/L)

5.78 ± 1.84

5.81 ± 1.78

-0.095

0.925

 LH (IU/L)

8.67(5.53, 12.60)

4.16(3.64, 5.39)

-5.547

< 0.001*

 E2 (pg/mL)

56.0(45.0, 68.5)

47.0(38.0, 59.7)

-2.844

0.004*

 P (ng/mL)

0.46(0.30, 0.70)

0.49(0.22, 0.60)

-0.506

0.613

 T (ug/L)

0.76 ± 0.27

0.47 ± 0.19

6.253

< 0.001*

 PRL (ug/L)

12.58 ± 5.74

10.80 ± 4.84

1.7

0.092

AMH (ng/mL)

7.55(5.00,10.62)

4.48(2.37, 6.48)

-4.701

< 0.001*

FPG (mmol/L)

4.87(4.60, 5.23)

4.75(4.52, 5.15)

-1.5

0.134

FINS (pmol/L)

75.0(58.1, 89.1)

52.0(40.5, 68.5)

-4.01

< 0.001*

HOMAIR

2.44(1.77, 2.91)

1.57(1.26, 2.08)

-4.319

< 0.001*

BMI (kg/m2)

22.7(20.1, 24.9)

21.3(19.1, 24.9)

-1.527

0.127

  1. Data are presented as the mean ± standard deviation, or median (interquartile range). FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; P, progestogens; T, testosterone; PRL, prolactin; AMH, anti-mullerian hormone; FPG, Fasting Plasma Glucose; FINS, Fasting Insulin; HOMAIR, homeostatic model assessment of insulin resistance; BMI, body mass index; P-value from Mann-Whitney U test or independent t-test for continuous variables. *P < 0.05 indicates a statistically significant association between the variables